Skip to main content

Site notifications

ADACEL (Sanofi-Aventis Australia Pty Ltd)

Product name
ADACEL
Date registered
Evaluation commenced
Decision date
Approval time
197 working days (255)
Active ingredients
pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed)
Registration type
EOI
Indication

ADACEL (suspension for injection) may now also be administered during pregnancy for prevention of pertussis in young infants via transplacental antibody transfer from the pregnant woman to the fetus.

Help us improve the Therapeutic Goods Administration site